BioPharma Co.'s $15M Deal Over Ruined J&J Vaccines OK'd
By Katryna Perera · August 7, 2025, 7:05 PM EDT
A Maryland federal judge on Thursday granted final approval to a $15 million settlement to close out a stockholder derivative suit claiming Emergent BioSolutions Inc. and its top brass made a...
To view the full article, register now.